|
Contents |
|
|
|
|
|
|
|
Case
Reports
|
 
|
|
|
|
Chikkannaiah P, Bharath RD, Sampath S, Santosh V.
De
novo gliosarcoma occurring in the posterior fossa of a 11-year-old girl.
Clin Neuropathol.
2012 Sep-Oct;31(5):389-91.
Abstract
| Full
text | Related
citations
|
|
|
Dipro S, Al-Otaibi F, Alzahrani A, Ulhaq A, Al Shail E.
Turcot
syndrome: a synchronous clinical presentation of glioblastoma multiforme and
adenocarcinoma of the colon.
Case Rep
Oncol Med. 2012;2012:720273. doi: 10.1155/2012/720273. Epub 2012 Oct
16.
Abstract
| Full
text | Related
citations
|
|
|
Hernandez-Gonzalez
G, Marchione P, De Angelis F, Giannone C, Kouleridou A, Spallone A.
Long-term
survival in cerebellar glioblastoma multiforme. Case report.
J Neurosurg Sci.
2012 Dec;56(4):379-81.
Abstract
| Related
citations
|
|
|
Sabatino G, Della Pepa GM, Esposito G, Brodbelt A.
Glioblastoma
multiforme intraxial metastasis to the conus medullaris with primary disease
under control: a rare unexpected finding.
Br J Neurosurg.
2012 Nov 7. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Taschner CA, Brendecke S, Weyerbrock A, Egger K, Prinz M.
Freiburg
neuropathology case conference: widespread mass lesions after resection of a
glioblastoma multiforme.
Clin Neuroradiol.
2012 Dec;22(4):375-80. doi: 10.1007/s00062-012-0179-5. Epub 2012 Nov 7.
Abstract
| Related
citations
|
|
|
Classification
|
|
|
|
|
Martini M, Cenci T, D'Alessandris GQ, Cesarini V, Cocomazzi A, Ricci-Vitiani
L, De Maria R, Pallini R, Maria Larocca L.
Epigenetic
silencing of Id4 identifies a glioblastoma subgroup with a better prognosis
as a consequence of an inhibition of angiogenesis.
Cancer. 2012 Nov 6. doi:
10.1002/cncr.27821. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Complications
|
|
|
|
|
Perry JR.
Thromboembolic
disease in patients with high-grade glioma.
Neuro Oncol. 2012 Sep;14
Suppl 4:iv73-80. doi: 10.1093/neuonc/nos197.
Abstract
| Related
citations
|
|
|
Schäfer A, Teufel J, Ringel F, Bettstetter M, Hoepner I, Rasper M, Gempt J,
Koeritzer J, Schmidt-Graf F, Meyer B, Beier CP, Schlegel J.
Aldehyde
dehydrogenase 1A1--a new mediator of resistance to temozolomide in
glioblastoma.
Neuro Oncol. 2012 Dec;14(12):1452-64.
doi: 10.1093/neuonc/nos270. Epub 2012 Nov 6.
Abstract
| Related
citations
|
|
|
Sengupta S, Marrinan J, Frishman C, Sampath P.
Impact
of temozolomide on immune response during malignant glioma chemotherapy.
Clin Dev
Immunol. 2012;2012:831090. doi: 10.1155/2012/831090. Epub 2012 Oct
24.
Abstract
| Full
text | Related
citations
|
|
|
Diagnosis
& Evaluation
|
|
|
|
|
Iacoangeli M, Di Rienzo A, Colasanti R, Zizzi A, Gladi M, Alvaro L, Nocchi
N, Di Somma LG, Scarpelli M, Scerrati M.
Endoscopy-verified
occult subependymal dissemination of glioblastoma and brain metastasis
undetected by MRI: prognostic significance.
Onco Targets Ther.
2012;5:449-56. doi: 10.2147/OTT.S39429. Epub 2012 Dec 13.
Abstract
| Full
text | Related
citations
|
|
|
Nakamura H, Murakami R, Hirai T, Kitajima M, Yamashita Y.
Can
MRI-derived factors predict the survival in glioblastoma patients treated
with postoperative chemoradiation therapy?
Acta
Radiol. 2012 Nov 8. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Nihashi T, Dahabreh IJ, Terasawa T.
Diagnostic
Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis.
AJNR Am
J Neuroradiol. 2012 Nov 1. [Epub ahead of print]
Abstract
| Full
text | Related
citations
|
|
|
Etiology
& Pathogenesis
|
|
|
|
|
Plate KH, Scholz A, Dumont DJ.
Tumor
angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.
Acta Neuropathol.
2012 Dec;124(6):763-75. doi: 10.1007/s00401-012-1066-5. Epub 2012 Nov 11.
Abstract
| Full
text | Related
citations
|
|
|
Seton-Rogers S.
Glioma:
Tumour cells in reverse.
Nat Rev Cancer.
2012 Dec;12(12):794. doi: 10.1038/nrc3404.
Abstract
| Related
citations
|
|
|
Integrative
Medicine
|
|
|
|
|
Podlech O, Harter PN, Mittelbronn M, Pöschel S, Naumann U.
Fermented
mistletoe extract as a multimodal antitumoral agent in gliomas.
Evid
Based Complement Alternat Med. 2012;2012:501796. doi:
10.1155/2012/501796. Epub 2012 Oct 22.
Abstract
| Full
text | Related
citations
|
|
|
Overall
Management
|
|
|
|
|
Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF.
Presentation,
management, and outcome of newly diagnosed glioblastoma in elderly patients.
J Neurosurg. 2012
Nov 23. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Prognosis
& Outcome
|
|
|
|
|
Fiorentino A, Fusco V.
Elderly
patients affected by glioblastoma treated with radiotherapy: the role of
serum hemoglobin level.
Int J
Neurosci. 2013 Feb;123(2):133-7. doi: 10.3109/00207454.2012.744309.
Epub 2012 Dec 6.
Abstract
| Related
citations
|
|
|
Stem
Cells
|
|
|
|
|
Mongiardi MP.
Angiogenesis
and hypoxia in glioblastoma: a focus on cancer stem cells.
CNS
Neurol Disord Drug Targets. 2012 Nov 1;11(7):878-83.
Abstract
| Related
citations
|
|
|
Yuan S, Wang F, Chen G, Zhang H, Feng L, Wang L, Colman H, Keating MJ, Li X,
Xu RH, Wang J, Huang P.
Effective
elimination of cancer stem cells by a novel drug combination strategy.
Stem Cells. 2013
Jan;31(1):23-34. doi: 10.1002/stem.1273. Epub 2012 Dec 19.
Abstract
| Full text
| Related
citations
|
|
|
Treatment
|
|
|
|
Overviews
|
|
|
|
|
Brandes AA, Bartolotti M.
Neuro-oncology:
treatment decisions in elderly patients with glioblastoma.
Nat Rev Neurol.
2012 Dec;8(12):664-5. doi: 10.1038/nrneurol.2012.220. Epub 2012 Nov 13.
Abstract
| Related
citations
|
|
|
Reijneveld JC, Klein M, Taphoorn MJ, Postma TJ, Heimans JJ.
Improved,
personalized treatment of glioma necessitates long-term follow-up of
cognitive functioning.
Pharmacogenomics. 2012
Nov;13(15):1667-9. doi: 10.2217/pgs.12.172.
Abstract
| Full
text | Related
citations
|
|
|
Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J.
Diagnostic
and therapeutic avenues for glioblastoma: no longer a dead end?
Nat Rev Clin
Oncol. 2012 Dec 11;10(1):14-26. doi: 10.1038/nrclinonc.2012.204. Epub
2012 Nov 27.
Abstract
| Full
text | Related
citations
|
|
|
Weller M, Cloughesy T, Perry JR, Wick W.
Standards
of care for treatment of recurrent glioblastoma--are we there yet?
Neuro Oncol. 2013 Jan;15(1):4-27.
doi: 10.1093/neuonc/nos273. Epub 2012 Nov 7.
Abstract
| Related
citations
|
|
|
Laboratory
Investigations
|
|
|
|
|
Hunn MK, Farrand KJ, Broadley KW, Weinkove R, Ferguson P, Miller RJ, Field
CS, Petersen T, McConnell MJ, Hermans IF.
Vaccination
with irradiated tumor cells pulsed with an adjuvant that stimulates NKT
cells is an effective treatment for glioma.
Clin
Cancer Res. 2012 Dec 1;18(23):6446-59. doi:
10.1158/1078-0432.CCR-12-0704. Epub 2012 Nov 12.
Abstract
| Related
citations
|
|
|
Zhang M, Lahn M, Huber PE.
Translating
the combination of TGFβ blockade and radiotherapy into clinical
development in glioblastoma.
Oncoimmunology. 2012 Sep
1;1(6):943-945.
Abstract
| Full
text | Related
citations
|
|
|
Clinical
Investigations
|
|
|
|
|
Akiyama Y, Oshita C, Kume A, Iizuka A, Miyata H, Komiyama M, Ashizawa T,
Yagoto M, Abe Y, Mitsuya K, Watanabe R, Sugino T, Yamaguchi K, Nakasu Y.
alpha-type-1
polarized dendritic cell-based vaccination in recurrent high-grade glioma: a
phase I clinical trial.
BMC Cancer. 2012 Dec
27;12(1):623. [Epub ahead of print]
Abstract
| Full
text | Related
citations
|
|
|
Bihan
C, Foscolo S, Boone M, Blonski M, Coutte A, Darlix A, Beauchesne P, Lefranc
M, Lorgis V, Taillandier L, Chauffert B.
Upfront
Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients
with Glioblastoma and Severe Neurological Impairment at Diagnosis.
Case Rep Oncol.
2012 Sep;5(3):530-6. doi: 10.1159/000343139. Epub 2012 Sep 29.
Abstract
| Full
text | Related
citations
|
|
|
Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG,
Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M,
Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M.
RTOG
0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for
Newly Diagnosed Glioblastoma Patients.
Int
J Radiat Oncol Biol Phys. 2012 Nov 22. doi:pii:
S0360-3016(12)03658-9. 10.1016/j.ijrobp.2012.10.008. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
D'Alessandris QG, Montano N, Cenci T, Martini M, Lauretti L, Bianchi F,
Larocca LM, Maira G, Fernandez E, Pallini R.
Targeted
therapy with bevacizumab and erlotinib tailored to the molecular profile of
patients with recurrent glioblastoma. Preliminary experience.
Acta Neurochir (Wien).
2013 Jan;155(1):33-40. doi: 10.1007/s00701-012-1536-5. Epub 2012 Nov 8.
Abstract
| Related
citations
|
|
|
Fiorentino A, Chiumento C, Caivano R, Cozzolino M, Pedicini P, Fusco V.
[Adjuvant
radiochemotherapy in the elderly affected by glioblastoma:
single-institution experience and literature review.]
Radiol Med. 2012 Nov
26. [Epub ahead of print] Italian.
Abstract
| Related
citations
|
|
|
Gürsel DB, Schlaff CD, Boockvar JA.
Trials
and tribulations of cancer immunotherapy: the dendritic cell vaccine shows
promise in a phase I glioblastoma multiforme trial.
Neurosurgery. 2012 Dec;71(6):N19-21.
doi: 10.1227/01.neu.0000423045.97311.f7.
Abstract
| Full
text | Related
citations
|
|
|
Guthrie GD, Eljamel S.
Impact
of particular antiepileptic drugs on the survival of patients with
glioblastoma multiforme.
J Neurosurg. 2012
Nov 23. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Minniti G, Scaringi C, De Sanctis V, Lanzetta G, Falco T, Di Stefano D,
Esposito V, Enrici RM.
Hypofractionated
stereotactic radiotherapy and continuous low-dose temozolomide in patients
with recurrent or progressive malignant gliomas.
J Neurooncol.
2012 Nov 6. [Epub ahead of print]
Abstract
| Full
text | Related
citations
|
|
|
Muhic A, Poulsen HS, Sorensen M, Grunnet K, Lassen U.
Phase
II open-label study of nintedanib in patients with recurrent glioblastoma
multiforme.
J Neurooncol.
2013 Jan;111(2):205-12. doi: 10.1007/s11060-012-1009-y. Epub 2012 Nov 27.
Abstract
| Full
text | Related
citations
|
|
|
Nossek E, Matot I, Shahar T, Barzilai O, Rapoport Y, Gonen T, Sela G, Korn
A, Hayat D, Ram Z.
Failed
awake craniotomy: a retrospective analysis in 424 patients undergoing
craniotomy for brain tumor.
J Neurosurg. 2012
Nov 2. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Salehi A, Chen CC, Carter BS.
Viral
vectors: promising new therapeutics in the battle against glioblastoma.
Expert Rev
Clin Pharmacol. 2012 Sep;5(5):489-91. doi: 10.1586/ecp.12.43.
Abstract
| Full
text | Related
citations
|
|
|
Weller M, Stupp R, Hegi ME, van den Bent M, Tonn JC, Sanson M, Wick W,
Reifenberger G.
Personalized
care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing
for malignant glioma patients in clinical practice.
Neuro Oncol. 2012 Sep;14
Suppl 4:iv100-8. doi: 10.1093/neuonc/nos206.
Abstract
| Related
citations
|
|
